motesanib
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for motesanib, covering 2011-01-21 to 2015-12-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer [Phase 3]